1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsATS Early Career Investigator Award in Pulmonary Vascular Disease is sponsored by American Thoracic Society. Supports early-career researchers conducting studies on pulmonary vascular disease, including the pathways and pathophysiology of pulmonary vascular disease.
Get alerted about grants like this
Save a search for “American Thoracic Society” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
American Thoracic Society | ATS Early Career Investigator Award in… ATS Early Career Investigator Award in Pulmonary Vascular Disease The ATS Early Career Investigator Award in Pulmonary Vascular Disease, sponsored by Johnson & Johnson, provides one-year mentored grants of up to $100,000 for rising researchers in the United States and Canada studying pulmonary hypertension.
The goal is to advance the understanding of pulmonary vascular pathobiology, improve medical care and enhance patients’ lives. Investigators may be working in basic, translational or clinical research. Actelion Pharmaceuticals US, Inc. (a Janssen pharmaceutical company of Johnson & Johnson), launched the program in 2005 as ENTELLIGENCE.
Since then, more than $7M has been awarded to 91 researchers in the United States and Canada. In late 2021, ENTELLIGENCE—now renamed the ATS Early Career Investigator Award in Pulmonary Vascular Disease—came to the ATS under the auspices of the Pulmonary Circulation Assembly.
In 2025 the ATS Early Career Investigator Award in Pulmonary Vascular Disease was folded into the ATS Research Program, providing greater visibility and impact across the organization and beyond. For current information regarding this grant, visit the ATS Research Program .
The ATS Early Career Investigator Award in Pulmonary Vascular Disease is sponsored by University of Colorado Anschutz Medical Campus Metabolic Mediators of Right Ventricular Dysfunction and Exercise Limitation Among Patients with Chronic Obstructive Pulmonary Disease-Associated Pulmonary Hypertension University of California San Francisco Sexual Dimorphic Effect of Dexamethasone in Hypoxic Pulmonary Hypertension University of South Alabama Regulation of Alternate Splicing in Hypoxic Pulmonary Vascular Cells The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension University of California, Los Angeles (UCLA) Dissecting a novel gene network at single-cell resolution in pulmonary arterial hypertension Jose Gomez-Arroyo, MD, PhD Role of FOXF1 in the Pathobiology of Pulmonary Arterial Hypertension Boston Children's Hospital The role of smooth muscle cell mediated Cxcl12/Cxcr4 pathway in a novel model of flow-induced pulmonary hypertension Board of Trustees of the Leland Stanford Junior University Defining the cellular and molecular basis of post-capillary vascular remodeling in pulmonary hypertension Regents of the University of Colorado The Role of Macrophages in Right Ventricular Adaptation to Pulmonary Hypertension Jasleen Minhas, MD, MS, MBBS Trustees of the University of Pennsylvania Phenotypes Based on Physical Activity Patterns in Pulmonary Arterial Hypertension Trustees of Indiana University The Novel Role of RASA3 in the Pathogenesis of Pulmonary Arterial Hypertension 3D Bioprinted Platforms to Study Cellular and Molecular Mechanisms of Pulmonary Vein Stenosis
Based on current listing details, eligibility includes: United States citizens, permanent residents, or Canadian citizens; junior faculty up to assistant professor, postdoctoral scholars, doctoral candidates, or fellows; applicants must complete primary research training by … Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $100,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.